Annual Gross Margin
61.90%
-8.84%-12.50%
December 31, 2023
Summary
- As of February 8, 2025, AKBA annual gross profit margin is 61.90%, with the most recent change of -8.84% (-12.50%) on December 31, 2023.
- During the last 3 years, AKBA annual gross margin has risen by +62.52% (+10083.87%).
- AKBA annual gross margin is now -35.69% below its all-time high of 96.26%, reached on December 31, 2018.
Performance
AKBA Gross Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Gross Margin
62.16%
+1.22%+2.00%
September 30, 2024
Summary
- As of February 8, 2025, AKBA quarterly gross profit margin is 62.16%, with the most recent change of +1.22% (+2.00%) on September 30, 2024.
- Over the past year, AKBA quarterly gross margin has increased by +1.22% (+2.00%).
- AKBA quarterly gross margin is now -41.44% below its all-time high of 106.15%, reached on December 31, 2022.
Performance
AKBA Quarterly Gross Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Gross Margin Formula
Gross Margin = Gross Profit
Revenue ✕ 100%
Revenue ✕ 100%
AKBA Gross Margin Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -12.5% | +2.0% |
| 3 y3 years | +10000.0% | +256.8% |
| 5 y5 years | -35.7% | +256.8% |
AKBA Gross Margin Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -12.5% | +114.9% | -41.4% | +256.8% |
| 5 y | 5-year | -12.5% | >+9999.0% | -41.4% | +166.3% |
| alltime | all time | -35.7% | >+9999.0% | -41.4% | +166.3% |
Akebia Therapeutics Gross Margin History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | 62.16%(+2.0%) |
| Jun 2024 | - | 60.94%(-5.4%) |
| Mar 2024 | - | 64.41%(-3.6%) |
| Dec 2023 | 61.90%(-12.5%) | 66.79%(+16.8%) |
| Sep 2023 | - | 57.17%(-17.6%) |
| Jun 2023 | - | 69.34%(+40.0%) |
| Mar 2023 | - | 49.53%(-53.3%) |
| Dec 2022 | 70.74%(+145.5%) | 106.15%(+395.6%) |
| Sep 2022 | - | 21.42%(-74.9%) |
| Jun 2022 | - | 85.28%(+73.3%) |
| Mar 2022 | - | 49.20%(+182.4%) |
| Dec 2021 | 28.81% | 17.42%(-74.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2021 | - | 67.30%(+8419.0%) |
| Jun 2021 | - | 0.79%(-97.7%) |
| Mar 2021 | - | 33.84%(-344.2%) |
| Dec 2020 | -0.62%(-101.1%) | -13.86%(-128.1%) |
| Sep 2020 | - | 49.41%(-152.7%) |
| Jun 2020 | - | -93.71%(-236.4%) |
| Mar 2020 | - | 68.68%(+52.1%) |
| Dec 2019 | 56.62%(-41.2%) | 45.16%(-22.7%) |
| Sep 2019 | - | 58.40%(-6.8%) |
| Jun 2019 | - | 62.63%(+9.9%) |
| Mar 2019 | - | 56.99%(-34.5%) |
| Dec 2018 | 96.26% | 87.02% |
FAQ
- What is Akebia Therapeutics annual gross profit margin?
- What is the all time high annual gross margin for Akebia Therapeutics?
- What is Akebia Therapeutics annual gross margin year-on-year change?
- What is Akebia Therapeutics quarterly gross profit margin?
- What is the all time high quarterly gross margin for Akebia Therapeutics?
- What is Akebia Therapeutics quarterly gross margin year-on-year change?
What is Akebia Therapeutics annual gross profit margin?
The current annual gross margin of AKBA is 61.90%
What is the all time high annual gross margin for Akebia Therapeutics?
Akebia Therapeutics all-time high annual gross profit margin is 96.26%
What is Akebia Therapeutics annual gross margin year-on-year change?
Over the past year, AKBA annual gross profit margin has changed by -8.84% (-12.50%)
What is Akebia Therapeutics quarterly gross profit margin?
The current quarterly gross margin of AKBA is 62.16%
What is the all time high quarterly gross margin for Akebia Therapeutics?
Akebia Therapeutics all-time high quarterly gross profit margin is 106.15%
What is Akebia Therapeutics quarterly gross margin year-on-year change?
Over the past year, AKBA quarterly gross profit margin has changed by +1.22% (+2.00%)